| Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid … T Antihypertensive, ... Jama 288 (23), 2981-2997, 2002 | 5205* | 2002 |
| 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension S Guideline J. Hypertens. 17, 151, 1999 | 1232* | 1999 |
| Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial … ALLHAT Collaborative Research Group Jama 283, 1967-1975, 2000 | 1096 | 2000 |
| Rationale and design for the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT) BR Davis, JA Cutler, DJ Gordon, CD Furberg, JT Wright Jr, WC Cushman, ... American journal of hypertension 9 (4), 342-360, 1996 | 775 | 1996 |
| Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care CD Furberg, JT Wright Jr, BR Davis, JA Cutler, M Alderman, H Black, ... | 688* | 2002 |
| Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril JT Wright, JK Dunn, JA Cutler, BR Davis, WC Cushman, CE Ford, ... Jama 293 (13), 1595-1608, 2005 | 528 | 2005 |
| Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to … PK Whelton, J Barzilay, WC Cushman, BR Davis, E IIamathi, JB Kostis, ... Archives of internal medicine 165 (12), 1401-1409, 2005 | 382 | 2005 |
| Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades FA McAlister, K Wilkins, M Joffres, FHH Leenen, G Fodor, M Gee, ... Cmaj 183 (9), 1007-1013, 2011 | 357 | 2011 |
| Results of the Ontario survey on the prevalence and control of hypertension FHH Leenen, J Dumais, NH McInnis, P Turton, L Stratychuk, K Nemeth, ... Cmaj 178 (11), 1441-1449, 2008 | 334 | 2008 |
| How NaCl raises blood pressure: a new paradigm for the pathogenesis of salt-dependent hypertension MP Blaustein, FHH Leenen, L Chen, VA Golovina, JM Hamlyn, TL Pallone, ... American Journal of Physiology-Heart and Circulatory Physiology 302 (5 …, 2012 | 325 | 2012 |
| 1999 Canadian recommendations for the management of hypertension RD Feldman, N Campbell, P Larochelle, P Bolli, ED Burgess, ... Cmaj 161 (12 suppl), S1-S17, 1999 | 235 | 1999 |
| Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid … FHH Leenen, CE Nwachuku, HR Black, WC Cushman, BR Davis, ... Hypertension 48 (3), 374-384, 2006 | 190 | 2006 |
| Increases in CSF [Na+] precede the increases in blood pressure in Dahl S rats and SHR on a high-salt diet BS Huang, BN Van Vliet, FHH Leenen American Journal of Physiology-Heart and Circulatory Physiology 287 (3 …, 2004 | 166 | 2004 |
| A solid silver clip for induction of predictable levels of renal hypertension in the rat. FH Leenen, W de Jong Journal of applied physiology 31 (1), 142-144, 1971 | 166 | 1971 |
| Distribution of epithelial sodium channels and mineralocorticoid receptors in cardiovascular regulatory centers in rat brain MS Amin, HW Wang, E Reza, SC Whitman, BS Tuana, FHH Leenen American Journal of Physiology-Regulatory, Integrative and Comparative …, 2005 | 163 | 2005 |
| 17β-Estradiol downregulates tissue angiotensin-converting enzyme and ANG II type 1 receptor in female rats SA Dean, J Tan, ER O'Brien, FHH Leenen American Journal of Physiology-Regulatory, Integrative and Comparative …, 2005 | 163 | 2005 |
| Both brain angiotensin II and “ouabain” contribute to sympathoexcitation and hypertension in Dahl S rats on high salt intake BS Huang, FHH Leenen Hypertension 32 (6), 1028-1033, 1998 | 156 | 1998 |
| The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker. M Ruzicka, B Yuan, E Harmsen, FH Leenen Circulation 87 (3), 921-930, 1993 | 149 | 1993 |
| Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial BR Davis, LB Piller, JA Cutler, C Furberg, K Dunn, S Franklin, D Goff, ... Circulation 113 (18), 2201-2210, 2006 | 148 | 2006 |
| Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring. FH Leenen, TW Wilson, P Bolli, P Larochelle, M Myers, SP Handa, ... The Canadian journal of cardiology 13 (10), 914-920, 1997 | 144 | 1997 |
Md Shahrier AminWest Virginia University在 hsc.wvu.edu 的电子邮件经过验证
